Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
The EMBO Journal|May 17, 2018
Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identityTatjana Dorn, Jessica Kornherr, Elvira I Parrotta, et al.Journal of the American College of Cardiology|March 25, 2017
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary EmbolismStavros V Konstantinides, Eric Vicaut, Thierry Danays, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 12, 2017
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trialChristian Hengstenberg, Jaya Chandrasekhar, Samantha Sartori, et al.Nature Communications|September 1, 2016
Regulation of monocyte cell fate by blood vessels mediated by Notch signallingJaba Gamrekelashvili, Roberto Giagnorio, Jasmin Jussofie, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2022
Endothelial Retargeting of AAV9 In VivoTarik Bozoglu, Seungmin Lee, Tilman Ziegler, et al.European Heart Journal. Cardiovascular Imaging|February 3, 2023
Machine learning identifies pathophysiologically and prognostically informative phenotypes among patients with mitral regurgitation undergoing transcatheter edge-to-edge repairTeresa Trenkwalder, Mark Lachmann, Lukas Stolz, et al.Science Translational Medicine|December 15, 2015
Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5Jean-Eric Alard, Almudena Ortega-Gomez, Kanin Wichapong, et al.Journal of the American College of Cardiology|October 20, 2015
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 TrialGeorge D Dangas, Thierry Lefèvre, Christian Kupatt, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 20, 2018
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trialStefano Barco, Mariaconcetta Russo, Eric Vicaut, et al.European Heart Journal|June 9, 2021
Myocardial hypoxic stress mediates functional cardiac extracellular vesicle releaseAchille Anselmo, Derk Frank, Laura Papa, et al.Pageof 17